Research and Development

GlaxoSmithKline has provided investors with details of a number of new oncology drugs it aims to launch over the next …

Accorda enrols first patient in phase III MS studyAcorda Therapeutics has begun a second phase III clinical study of Fampridine-SR …

DNA samples from 17,000 people across the UK have helped a consortium of scientists to pinpoint genes responsible for diseases …

Contract research organisation Quintiles is to spend £7.5 million (€11 million) on a new home for its Scottish product development …

Amgen has spent $720 million acquiring two US biotech companies in deals that add potential treatments for diabetes and kidney …

Genzyme is to spend $345 million on acquiring specialist pharma company Bioenvision and its oncology portfolio.Genzyme already co-markets with Bioenvision …

Two key Pfizer executives are to step down as the company continues its drive to reinvigorate itself.The departures follow the …

FDA requests additional efficacy data for Dendreon's Provenge in advanced prostate cancer.Dendreon has received a complete response letter from the …

Nearly 1,000 potential future medicines are in the pipelines of some 50 companies operating in the UK, a survey by …

Smokers who are addicted to the nicotine in their daily cigarettes could soon receive a vaccine to help them kick …

AstraZeneca has entered the lucrative vaccine market and gained a range of potential new biologic products with the $15.6 billion …

Additional indication for Pfizer's FragminThe FDA has approved a new indication for blood clot drug Fragmin to treat symptomatic venous …

Common pain medications do not prevent Alzheimer's diseaseOver-the-counter pain medication naproxen and prescription pain reliever celecoxib do not prevent Alzheimer's …

Gemin X compound effective in leukemiaGemin X has said its compound that treats acute lymphoblastic leukemia produced positive results in …

Schering-Plough receives Japanese approval for ZetiaSchering-Plough has received Japanese marketing approval for Zetia, a cholesterol-lowering agent that inhibits the absorption …